Compare MAMA & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAMA | PSNL |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | 581 | N/A |
| Industry | Specialty Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 558.2M | 729.1M |
| IPO Year | 2011 | 2019 |
| Metric | MAMA | PSNL |
|---|---|---|
| Price | $14.16 | $5.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $19.00 | $12.20 |
| AVG Volume (30 Days) | 367.2K | ★ 1.7M |
| Earning Date | 04-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.44 | 33.58 |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $95,420,129.00 | $69,648,000.00 |
| Revenue This Year | $31.09 | $15.34 |
| Revenue Next Year | $16.12 | $41.46 |
| P/E Ratio | $109.08 | ★ N/A |
| Revenue Growth | ★ 95.54 | N/A |
| 52 Week Low | $6.37 | $3.84 |
| 52 Week High | $17.85 | $11.50 |
| Indicator | MAMA | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 42.92 | 40.10 |
| Support Level | $9.97 | $4.65 |
| Resistance Level | $14.92 | $6.99 |
| Average True Range (ATR) | 0.79 | 0.43 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 27.86 | 34.29 |
Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.